Access nucleic acid quantification with superior accuracy, precision and relative sensitivity

Our dPCR expertise

CellCarta’s Center of Excellence for development of complex genomic biomarker assays located in Ghent (Belgium) was the first European laboratory to commercially offer the dPCR technology and is still at the forefront of digital PCR-based research.

As expert dPCR service provider, our team supports any dPCR-based application, using either off-the-shelf assays or including custom primer design, all performed in an ISO 17025 accredited environment. We developed a close collaboration with Bio-Rad and are using Bio‑Rad’s QX200™ Digital Droplet PCR™ technology.

Key applications of dPCR

dPCR enables nucleic acid quantification with superior accuracy, precision and relative sensitivity. This technology excels in:

  • Quantification of low abundant genes or small differences
  • Absolute quantification
  • Gene Copy Number Variation (CNV)
  • Vector Copy Number (VCN) determination and Replication Competent Retrovirus (RCR) or Lentivirus (RCL) detection, in the context of adoptive cell therapies
  • Rare event detection, such as cancer gene mutations in tissue or liquid biopsy

As absolute concentrations are determined, data can be easily interpreted and compared across different samples and experiments, especially in a clinical setting.

Choosing between dPCR and qPCR

Digital PCR leads to absolute quantification and does not require the use of standard curves as qPCR. The assay particularly excels in providing the quantification of low abundant targets or small differences.

Learn more about the intrinsic potential our digital droplet PCR (ddPCR) assays in clinical studies with 4 applications performed by our team:

  • Rare variant analysis in cell-free DNA (cfDNA)
  • Quantification of small changes in alternative splicing
  • Absolute quantification of CAR T cells biodistribution
  • Absolute quantification of CAR T vectors in clinical trial

Related Services